Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Palatin Technologies, Inc. (PTN)

Pharmaceutical Preparations

https://www.palatin.com

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.

4B CEDAR BROOK DRIVE
CRANBURY, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/04/1993

Market Cap

27,602,108

Shares Outstanding

13,740,000

Weighted SO

13,737,137

Total Employees

N/A

Upcoming Earnings

09/26/2024

Similar Tickers

FBIO --.--%

CKPT --.--%

ATXI --.--%

PIRS --.--%

ALRN --.--%

ACGN --.--%

QNRX --.--%

COCP --.--%

IBIO --.--%

Beta

1.0120

Last Div

0.0000

Range

1.29-5.65

Chg

0.0550

Avg Vol

103251

Mkt Cap

27602108

Exch

AMEX

Country

US

Phone

609 495 2200

DCF Diff

0.8957

DCF

0.5143

Div Yield

0.0000

P/S

4.6767

EV Multiple

-0.5858

P/FV

14.2528

Div Yield %

0.0000

P/E

-0.6844

PEG

-0.0210

Payout

0.0000

Current Ratio

1.2034

Quick Ratio

1.2034

Cash Ratio

1.1736

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1746.4664

CCC

-1746.4664

Gross Margin

0.8781

Op Margin

-5.5524

Pretax Margin

-5.5714

Net Margin

-5.5714

Eff Tax Rate

-0.0004

ROA

-2.8829

ROE

9.0583

ROCE

-11.4045

NI/EBT

1.0000

EBT/EBIT

1.0034

EBIT/Rev

-5.5524

Debt Ratio

0.0620

D/E

0.4475

LT Debt/Cap

0.1424

Total Debt/Cap

0.3092

Int Coverage

-2151.5616

CF/Debt

-48.9566

Equity Multi

7.2240

Rec Turnover

0.0000

Pay Turnover

0.2090

Inv Turnover

0.0000

FA Turnover

5.4614

Asset Turnover

0.5174

OCF/Share

-2.1906

FCF/Share

-2.1963

Cash/Share

0.6341

OCF/Sales

-5.8615

FCF/OCF

1.0026

CF Coverage

-48.9566

ST Coverage

-77.8423

CapEx Coverage

-384.3391

Div&CapEx Cov

-384.3391

P/BV

14.2528

P/B

14.2528

P/S

4.6767

P/E

-0.6844

P/FCF

-0.7958

P/OCF

-0.6505

P/CF

-0.6505

PEG

-0.0210

P/S

4.6767

EV Multiple

-0.5858

P/FV

14.2528

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 05, 13:38 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, SPTN, IGMS on Behalf of Shareholders Benzinga Jul 03, 21:30 $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: DNOW, ENZB, SPTN, and BASE GlobeNewswire Inc. Apr 04, 23:00 $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF GlobeNewswire Inc. Mar 20, 01:45 Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call Benzinga Mar 20, 01:25 Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) GlobeNewswire Inc. Mar 20, 01:25 Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) GlobeNewswire Inc. Feb 09, 21:40 Data la crescita esponenziale del settore del turismo in Arabia Saudita, dmg events annuncia il salone Hotel & Hospitality Expo GlobeNewswire Inc. Oct 24, 23:47 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates YOTA, PWUP, CPTN, INSI on Behalf of Shareholders Benzinga Dec 06, 14:45 Gold Moves Higher; Campbell Soup Earnings Top Expectations Benzinga Dec 06, 14:43 Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Revenue Product Segmentation